146 related articles for article (PubMed ID: 12948927)
1. Candesartan cilexetil induced pustular psoriasis.
Kawamura A; Ochiai T
Eur J Dermatol; 2003; 13(4):406-7. PubMed ID: 12948927
[TBL] [Abstract][Full Text] [Related]
2. [Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)].
Baumgart P; Reismann J; Pohlmeyer H; Düsing R
Dtsch Med Wochenschr; 2001 May; 126(19):547-50. PubMed ID: 11402910
[TBL] [Abstract][Full Text] [Related]
3. Improving antihypertensive efficacy while maintaining placebo-like tolerability.
Sever PS
Blood Press Suppl; 2000; 1():19-22. PubMed ID: 11059631
[TBL] [Abstract][Full Text] [Related]
4. Candesartan cilexetil: a new, long-acting, effective angiotensin II type 1 receptor blocker.
Sever P
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S91-5. PubMed ID: 9331018
[TBL] [Abstract][Full Text] [Related]
5. Switch from ABCD pretreatment to A-II-A treatment: a multinational, open, centrally randomized, prospective parallel group comparison.
Asmar R; Porcellati C; Dusing R
Drugs Exp Clin Res; 2004; 30(4):153-61. PubMed ID: 15553661
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive effects of candesartan cilexetil, enalapril and placebo.
Franke H
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S61-2. PubMed ID: 9331010
[No Abstract] [Full Text] [Related]
7. Efficacy and tolerability of candesartan cilexetil in special patient groups.
Trenkwalder P
Blood Press Suppl; 2000; 1():27-30. PubMed ID: 11059633
[TBL] [Abstract][Full Text] [Related]
8. Candesartan cilexetil and enalapril are of equivalent efficacy in patients with mild to moderate hypertension.
Zanchetti A; Omboni S; Di Biagio C
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S57-9. PubMed ID: 9331009
[No Abstract] [Full Text] [Related]
9. Candesartan cilexetil: safety and tolerability in healthy volunteers and patients with hypertension.
Belcher G; Hübner R; George M; Elmfeldt D; Lunde H
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S85-9. PubMed ID: 9331017
[TBL] [Abstract][Full Text] [Related]
10. Differences among angiotensin II type 1 receptor blockers: characteristics of candesartan cilexetil.
Unger T
Blood Press Suppl; 2000; 1():14-8. PubMed ID: 11059630
[TBL] [Abstract][Full Text] [Related]
11. Exploring new treatment strategies in heart failure.
Swedberg K
Blood Press Suppl; 2000; 1():44-8. PubMed ID: 11059637
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of candesartan after single and repeated doses of candesartan cilexetil in young and elderly healthy volunteers.
Hübner R; Högemann AM; Sunzel M; Riddell JG
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S19-25. PubMed ID: 9331000
[TBL] [Abstract][Full Text] [Related]
13. [Angiotensin receptor antagonist for therapy of patients with hypertension].
Rakugi H; Ogihara T
Nihon Rinsho; 1997 Aug; 55(8):2075-80. PubMed ID: 9284426
[TBL] [Abstract][Full Text] [Related]
14. Achieving quality 24-h blood pressure control with candesartan cilexetil.
Meredith P
Blood Press Suppl; 2000; 1():23-6. PubMed ID: 11059632
[TBL] [Abstract][Full Text] [Related]
15. Candesartan in the treatment of hypertension: what have we learnt in the last decade?
Barrios V; Escobar C
Expert Opin Drug Saf; 2011 Nov; 10(6):957-68. PubMed ID: 21848481
[TBL] [Abstract][Full Text] [Related]
16. Dose-finding study of candesartan cilexetil plus hydrochlorothiazide in patients with mild to moderate hypertension.
Philipp T; Letzel H; Arens HJ
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S67-8. PubMed ID: 9331013
[No Abstract] [Full Text] [Related]
17. Long-acting blood pressure reduction by candesartan cilexetil in patients with hypertension.
Bönner G; Fuchs W
Curr Med Res Opin; 2005 Jun; 21(6):935-40. PubMed ID: 15969893
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with candesartan cilexetil plus hydrochlorothiazide in patients unresponsive to low-dose hydrochlorothiazide.
Plouin PF
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S65-6. PubMed ID: 9331012
[No Abstract] [Full Text] [Related]
19. Improving prognosis in hypertension: exploring the benefits of angiotensin II type 1 receptor blockade.
Ruilope L
Blood Press Suppl; 2000; 1():31-5. PubMed ID: 11059634
[TBL] [Abstract][Full Text] [Related]
20. Role of the renin-angiotensin system in hypertension in the elderly.
Nagano M; Higaki J; Mikami H; Ogihara T
Blood Press Suppl; 1994; 5():130-3. PubMed ID: 7889195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
